Skip to main content
SpringerLink
Log in

Gamma-glutamyl transpeptidase and the metabolic syndrome in a Taiwanese aboriginal population

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

The prevalence of metabolic syndrome (MetS) depends on the population, geographic region, and urbanization. Currently, there are no data on the prevalence of MetS among Taiwanese aboriginal populations. The present study aims to determine the prevalence of MetS in a Taiwanese aboriginal population, as well as determine the relationship between serum gamma glutamyl transferase (GGT) and MetS. This study was a population-based, cross-sectional study conducted in the remote area of the Fuxing Township, Taoyuan County in Taiwan. A total of 195 highland aboriginal individuals from the Atayal tribe were enrolled, of whom 84 (43.1 %) were male and 111 (56.9 %) were female. The prevalence rates of MetS and its risk factors at different serum GGT levels were determined. The prevalence of MetS, according to the revised NCEP/ATPIII criteria, was 48.7 % in the Atayal tribe (i.e. 42.9 % in males and 53.2 % in females). After adjusting for age, sex, alcohol consumption, alanine aminotransferase, and aspartate transaminase, the odds ratios (OR) for MetS across the serum GGT tertiles (i.e. 1–27 U/L, 28–54 U/L, and ≥55 U/L in men; and 1–22 U/L, 23–44 U/L and ≥45 U/L in women) were 1, 1.7 (95 % CI: 1.2–2.7), and 3.1 (95 % CI: 1.4–7.2), respectively. Central obesity was the most common risk factor for MetS, and the higher GGT tertile was significantly associated with higher waist circumference and triglyceride levels. These findings suggest that the overall prevalence of MetS is higher in the highland aboriginal population than the metropolitan populations of Taiwan. Additionally, higher serum GGT levels are significantly associated with MetS and its risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N. Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb. 2009;16:355–62.

    Article  PubMed  CAS  Google Scholar 

  2. Lin CC, Liu CS, Lai MM, Li CI, Chen CC, Chang PC, et al. Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Publ Health. 2007;7:239.

    Article  Google Scholar 

  3. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130–7.

    Article  PubMed  CAS  Google Scholar 

  4. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995;142:699–708.

    PubMed  CAS  Google Scholar 

  5. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005;112:2078–80.

    Article  PubMed  Google Scholar 

  6. Lee DH, Blomhoff R, Jacobs Jr DR. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38:535–9.

    Article  PubMed  CAS  Google Scholar 

  7. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263–355.

    Article  PubMed  CAS  Google Scholar 

  8. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care. 1998;21:732–7.

    Article  PubMed  CAS  Google Scholar 

  9. Anderson ME, Allison RD, Meister A. Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci U S A. 1982;79:1088–91.

    Article  PubMed  CAS  Google Scholar 

  10. Bureau of Health Promotion Database. The criteria of metabolic syndrome 2012. Available from http://www.bhp.doh.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?id=200712250123&parentid=200712250023.

  11. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992;5:207–9.

    Google Scholar 

  12. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105:626–35.

    Article  PubMed  Google Scholar 

  13. Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome. The Tromso Study 1979–2001. Diabetes Res Clin Pract. 2007;78:217–24.

    Article  PubMed  Google Scholar 

  14. Chen CC, Li TC, Chang PC, Liu CS, Lin WY, Wu MT, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism. 2008;57:544–8.

    Article  PubMed  CAS  Google Scholar 

  15. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2954–9.

    Article  PubMed  Google Scholar 

  16. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000;283:2253–9.

    Article  PubMed  CAS  Google Scholar 

  17. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res. 2003;11:1223–31.

    Article  PubMed  Google Scholar 

  18. Lemieux I. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? Arterioscler Thromb Vasc Biol. 2004;24:795–7.

    Article  PubMed  CAS  Google Scholar 

  19. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288:H2031–41.

    Article  PubMed  CAS  Google Scholar 

  20. Skolnik EY, Marcusohn J. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev. 1996;7:161–73.

    Article  PubMed  CAS  Google Scholar 

  21. Després J-P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Soc Cardiol. 2006;8:4–12.

    Google Scholar 

  22. Despres J. Inflammation and cardiovascular disease: is abdominal obesity the missing link? Int J Obes Relat Metab Disord. 2003;27:s22–4.

    Article  PubMed  Google Scholar 

  23. Karp DR, Shimooku K, Lipsky PE. Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem. 2001;276:3798–804.

    Article  PubMed  CAS  Google Scholar 

  24. Hanigan MH, Ricketts WA. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry. 1993;32:6302–6.

    Article  PubMed  CAS  Google Scholar 

  25. Hochwald SN, Harrison LE, Rose DM, Anderson M, Burt ME. gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst. 1996;88:193–7.

    Article  PubMed  CAS  Google Scholar 

  26. Lee DH, Jacobs Jr DR. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis. 2005;178:327–30.

    Article  PubMed  CAS  Google Scholar 

  27. Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003;27 Suppl 3:S53–5.

    Article  PubMed  CAS  Google Scholar 

  28. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127–33.

    Article  PubMed  CAS  Google Scholar 

  29. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248:230–8.

    Article  PubMed  CAS  Google Scholar 

  30. Lee DH, Ha MH, Kim JR, Gross M, Jacobs Jr DR. Gamma-glutamyltransferase, alcohol, and blood pressure. A 4 year follow-up study. Ann Epidemiol. 2002;12:90–6.

    Article  PubMed  Google Scholar 

  31. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyltransferase and diabetes–a 4 year follow-up study. Diabetologia. 2003;46:359–64.

    Article  PubMed  CAS  Google Scholar 

  32. Sobngwi E, Mbanya JC, Unwin NC, Porcher R, Kengne AP, Fezeu L, et al. Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. Int J Epidemiol. 2004;33:769–76.

    Article  PubMed  Google Scholar 

  33. Gao M, Ikeda K, Hattori H, Miura A, Nara Y, Yamori Y. Cardiovascular risk factors emerging in Chinese populations undergoing urbanization. Hypertens Res. 1999;22:209–15.

    Article  PubMed  CAS  Google Scholar 

  34. Ramachandran A, Snehalatha C, Latha E, Manoharan M, Vijay V. Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract. 1999;44:207–13.

    Article  PubMed  CAS  Google Scholar 

  35. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.

    Google Scholar 

Download references

Acknowledgments

We thank Chang Gung Medical Research Progress Grant (CMRPG390492) for supporting this study and Biostatistical Center of Clinical Research for the statistic counseling.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Family Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 5, Fu-Hsin Street, Taoyuan, Taiwan

    Chih-I Ho, Yu-Chung Tsao, Jau-Yuan Chen, Ko-Chen Chang, Yi-Wen Tsai, Jung-soon Lin & Shy-Shin Chang

Authors
  1. Chih-I Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-Chung Tsao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jau-Yuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ko-Chen Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi-Wen Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jung-soon Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shy-Shin Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shy-Shin Chang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ho, CI., Tsao, YC., Chen, JY. et al. Gamma-glutamyl transpeptidase and the metabolic syndrome in a Taiwanese aboriginal population. Int J Diabetes Dev Ctries 33, 147–154 (2013). https://doi.org/10.1007/s13410-013-0127-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-013-0127-1

Keywords

Search

Navigation